Acute thrombocytopenia and fibrinogen reduction occurring after nintedanib treatment for immune checkpoint inhibitor-related pneumonia: a case report

Acute thrombocytopenia and fibrinogen reduction occurring after nintedanib treatment for immune checkpoint inhibitor-related pneumonia: a case report

BackgroundNintedanib, a small molecule multi-target tyrosine kinase inhibitor, can block the fibrosis process and slow disease progression. Acute thrombocytopenia and fibrinogen reduction caused by nintedanib is a rare clinical event, with few studies reported.Case presentationWe report the case of...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jian Zheng, Nan Zhou, Dexiang Pang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2025-08-01
Series:	Frontiers in Oncology
Subjects:	drug-induced thrombocytopenia fibrinogens abnormal checkpoint inhibitor pneumonitis nintedanib case report
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1561440/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Can Pirfenidone and Nintedanib Be Alternative Treatment Options for Radiation Pneumonitis?
by: Hikmet COBAN, et al.
Published: (2025-06-01)

Development and validation of a nomogram for differentiating immune checkpoint inhibitor-related pneumonitis from pneumonia in patients undergoing immunochemotherapy: a multicenter, real-world, retrospective study
by: Linli Duan, et al.
Published: (2025-05-01)

Potential of anticoagulant therapy in cardiology practice for thrombocytopenia. Literature review
by: K. G. Pereverzeva, et al.
Published: (2023-09-01)

HEPARIN-INDUCED THROMBOCYTOPENIA IN PATIENT POST LIVER TRANSPLANTATION
by: M. Sh. Hubutija, et al.
Published: (2018-04-01)

The Role of Albumin-To-Fibrinogen and Fibrinogen-To-Prealbumin Ratios in the Development of Ovarian Carcinoma
by: Racheva V., et al.
Published: (2025-03-01)

Nintedanib alleviates hyperoxia-induced lung injury via targeting NF-κB signalling pathway in rat model of bronchopulmonary dysplasia
by: Rui Hao, et al.
Published: (2025-06-01)

Therapeutic efficacy of pirfenidone and nintedanib in pulmonary fibrosis; a systematic review and meta-analysis
by: Yiting Qiu, et al.
Published: (2025-07-01)

Fibrinogen and Neuroinflammation in the Neurovascular Unit in Stroke
by: Chen Y, et al.
Published: (2025-04-01)

Vaccine-induced immune thrombotic thrombocytopenia: definition, risks with different vaccines, and regulatory responses
by: S. V. Akinshina, et al.
Published: (2021-11-01)

Investigating thrombocytopenia in Meropenem-treated patients: a cross-sectional observational study
by: Ahmed E. Altyar, et al.
Published: (2025-07-01)

Ventricular septal rupture after acute myocardial infarction in a patient with venous thromboembolism complicated by thrombocytopenia: A case report
by: Yuansong Zhu, et al.
Published: (2023-03-01)

Imaging features and prognostic significance of immune checkpoint inhibitor–related pneumonitis in NSCLC
by: Xueqi Wang, et al.
Published: (2025-07-01)

Post-marketing safety concerns with pirfenidone and nintedanib: an analysis of individual case safety reports from the FDA adverse event reporting system database and the Japanese adverse drug event report databases
by: Tao Wang, et al.
Published: (2025-04-01)

Thrombocytopenia as a Side Effect of Heparin Therapy and COVID-19 Vaccination: A Review
by: S. S. Postnikov, et al.
Published: (2025-06-01)

C-Reactive Protein to Albumin Ratio and Albumin to Fibrinogen Ratio in Rheumatoid Arthritis Patients
by: Elsabagh Abdou Amira, et al.
Published: (2022-05-01)

Gynecologic and obstetric complications in women with congenital fibrinogen disorders: insights from the Prospective Rare Bleeding Disorders Database
by: Samin Mohsenian, et al.
Published: (2025-07-01)

Association between fibrinogen levels and mortality following cardiopulmonary resuscitation: a retrospective cohort study
by: Xin Cheng, et al.
Published: (2025-09-01)

Approaches for prevention and management of menstrual bleeding in adolescent patients undergoing cancer treatment
by: L. V. Adamyan, et al.
Published: (2025-03-01)

Should thrombopoietin receptor agonists be used for chemotherapy-induced thrombocytopenia?
by: Hanny Al-Samkari
Published: (2025-07-01)

Fibrinogen, FDP and D-Dimer as Potential Biomarkers for Disease Severity in Ulcerative Colitis: A Retrospective Study
by: Feng W, et al.
Published: (2024-11-01)

The Effect of 8 Weeks of Combined Training with Consuming Methadone on Plasma Fibrinogen & CRP on withdrawal Addiction Women
by: Motahhareh Borsalani, et al.
Published: (2020-07-01)

Initial Data on Clinical Use of Generic Romiplostim for Second-Line and Subsequent Therapy of Immune Thrombocytopenia in India
by: Suvir Singh, et al.
Published: (2021-01-01)

The association between rs1800790 and rs1800787 variants in fibrinogen beta chain and venous thromboembolism among Arabs
by: Rafat M. Al-Awad, et al.
Published: (2025-12-01)

Encapsulation of fibrinogen and thrombin with calcium carbonate for hemorrhage control
by: Henry T Peng, et al.
Published: (2023-07-01)

Immune thrombocytopenia: literature review
by: S. G. Zakharov
Published: (2024-09-01)

Fibrinogen albumin ratio as a predictor marker of disease activity in ankylosing spondylitis
by: Mennatallah Mohammed Mohammed Mustafa, et al.
Published: (2025-07-01)

Correlation between plasma fibrinogen levels and microvascular complications in type 2 diabetes
by: Hamidullah, et al.
Published: (2024-07-01)

Reactive Nitrogen Species and Fibrinogen: Exploring the Effects of Nitration on Blood Clots
by: Francesca Nencini, et al.
Published: (2025-07-01)

Emulsion-Based Encapsulation of Fibrinogen with Calcium Carbonate for Hemorrhage Control
by: Henry T. Peng, et al.
Published: (2025-03-01)

Immune paradoxes of vaccine-induced thrombotic thrombocytopenia (VITТ), heparin-induced thrombocytopenia (HIT) and thrombosis: from general mechanisms to the unique VITТ and HIT course
by: A. D. Makatsariya, et al.
Published: (2025-03-01)

Association of clinical factors with thrombocytopenia in patients receiving linezolid treatment: a retrospective study
by: Le Thi Phuong Thao, et al.
Published: (2024-02-01)

Fibrinogen and D-dimer protein levels in patients with preeclampsia: a systematic review and meta-analysis
by: Ermiyas Alemayehu, et al.
Published: (2025-08-01)

A Life-threatening Adverse Effect of Taurine-containing Energy Drink: Thrombocytopenia
by: Erhan Özyurt, et al.
Published: (2024-03-01)

Fibrinogen-Albumin Ratio: An Independent Recurrence Factor for Colorectal Cancer Stages II and III in a Competing Risk Model
by: Michiaki Shimada, et al.
Published: (2025-07-01)

Plasma fibrinogen levels towards cancer incidence: a systematic review and meta-analysis of epidemiological studies
by: Yuexin Luo, et al.
Published: (2025-05-01)

Clinical spectrum of thrombocytopenia - A hospital based prospective study
by: Bansuri Patni, et al.
Published: (2024-12-01)

Immune thrombocytopenia: clinical manifestation and therapy response. The interim analysis of Russian register of patients with primary immune thrombocytopenia and literature review
by: I. A. Lisukov, et al.
Published: (2014-07-01)

Fibrinogen-to-albumin ratio (FAR) for predicting microvascular flap complications in reconstructive surgery
by: Rihards Peteris Rocans, et al.
Published: (2025-06-01)

Correlation of fibrinogen levels with acute myocardial infarction risk in the Chinese Han population
by: Jian-Ping Xu, et al.
Published: (2025-07-01)

A study to determine utility of platelet indices in differentiating hyperdestructive and hypoproductive thrombocytopenia.
by: Shruthi Neelakanth Shetageri, et al.
Published: (2024-10-01)